Clinical Trial Update: Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention [NA]

View source ↗

Summary

A completed Yale University clinical trial evaluated whether adding cognitive behavioral therapy after esketamine treatment can prevent relapse in adults with m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Suicidal Ideation

Drugs mentioned

• SPRAVATO (ESKETAMINE HYDROCHLORIDE)

Snippet

Sponsor: Yale University | Conditions: Depression and Suicide | NA | Status: COMPLETED